Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Langer

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicityS W Langer, G Schmidt, M Sørensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Dexrazoxane in anthracycline extravasationS W Langer, M Sehested, P B Jensen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 10, 2006
Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapyJ Herrstedt, T C Sigsgaard, H A Nielsen, et al.
Lung Cancer (Amsterdam, Netherlands)|August 5, 2019
Erratum to "Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence" [Lung Cancer 132 (June) (2019) 141-149]V Grøndahl, T Binderup, S W Langer, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of ExcellenceV Grøndahl, T Binderup, S W Langer, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 1996
Brain relapses in chemotherapy-treated small cell lung cancer: a retrospective review of two time-dose regimens of therapeutic brain irradiationF Bach, J B Sørensen, L Adrian, et al.
Ugeskrift for Laeger|March 15, 1993
[The value of bone marrow scintigraphy in patients with recurrent breast cancer]S W Langer, C Kamby, H S Thomsen, et al.
Journal of Neuroendocrinology|June 27, 2024
NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasmsH Sorbye, G O Hjortland, L W Vestermark, et al.
British Journal of Cancer|July 17, 1999
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapyT Sigsgaard, J Herrstedt, L J Andersen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2006
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysisB M Fischer, J Mortensen, S W Langer, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicityS W Langer, G Schmidt, M Sørensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Dexrazoxane in anthracycline extravasationS W Langer, M Sehested, P B Jensen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 10, 2006
Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapyJ Herrstedt, T C Sigsgaard, H A Nielsen, et al.
Lung Cancer (Amsterdam, Netherlands)|August 5, 2019
Erratum to "Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence" [Lung Cancer 132 (June) (2019) 141-149]V Grøndahl, T Binderup, S W Langer, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of ExcellenceV Grøndahl, T Binderup, S W Langer, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 1996
Brain relapses in chemotherapy-treated small cell lung cancer: a retrospective review of two time-dose regimens of therapeutic brain irradiationF Bach, J B Sørensen, L Adrian, et al.
Ugeskrift for Laeger|March 15, 1993
[The value of bone marrow scintigraphy in patients with recurrent breast cancer]S W Langer, C Kamby, H S Thomsen, et al.
Journal of Neuroendocrinology|June 27, 2024
NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasmsH Sorbye, G O Hjortland, L W Vestermark, et al.
British Journal of Cancer|July 17, 1999
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapyT Sigsgaard, J Herrstedt, L J Andersen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2006
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysisB M Fischer, J Mortensen, S W Langer, et al.
Pageof 3